NNNN
Anbio Biotechnology Class A Ordinary SharesNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$1.18B
P/E Ratio
179.60
EPS
$0.15
Beta
—
52W High
$55.65
52W Low
$5.99
50-Day MA
$23.92
200-Day MA
$32.49
Dividend Yield
—
Profit Margin
37.20%
Forward P/E
—
PEG Ratio
—
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Fundamentals
| Revenue (TTM) | $6.92M |
| Gross Profit (TTM) | $6.21M |
| EBITDA | — |
| Operating Margin | 73.50% |
| Return on Equity | 11.20% |
| Return on Assets | 4.73% |
| Revenue/Share (TTM) | $0.16 |
| Book Value | $0.63 |
| Price-to-Book | 41.57 |
| Price-to-Sales (TTM) | 170.87 |
| EV/Revenue | 163.54 |
| EV/EBITDA | 528.40 |
| Quarterly Earnings Growth (YoY) | 2.80% |
| Quarterly Revenue Growth (YoY) | -21.60% |
| Shares Outstanding | $43.89M |
| Float | $39.69M |
| % Insiders | 4.79% |
| % Institutions | 4.85% |
Data last updated: 4/9/2026